Add office photos
Engaged Employer
Abbott
4.1
based on 3.3k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Abbott
Company Summary
Abbott's life-changing technology helps people live fully and offers information, medicines and breakthroughs to help manage people's health.
Overall Rating
4.1/5
based on 3.3k reviews
5% above
industry average
Highly rated for
Company culture, Salary, Work-life balance
Critically rated for
Promotions
Work Policy
Work from office
54% employees reported
Monday to Saturday
49% employees reported
Flexible timing
70% employees reported
Within city
44% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
268 employees reported
Health insurance
250 employees reported
Office cab/shuttle
93 employees reported
Professional degree assistance
89 employees reported
View all benefits
About Abbott
Founded in1888 (137 yrs old)
India Employee Count1k-5k
Global Employee Count10k-50k
India HeadquartersMumbai, Maharashtra, India
Websiteabbott.com
Primary Industry
Other Industries
View in video summary
CREATING LIFE-CHANGING TECHNOLOGY
At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love.
With headquarters in north suburban Chicago, we serve people in more than 160 countries with leading medical devices, diagnostics, nutrition products, and branded generic medicines. Our 114,000 colleagues are helping millions of people to live better and healthier, every day around the world.
Mission: Live your best life, now and in the future
We understand that the first step to living your best life is good health. Everything we make is designed to help you do just that. That’s our commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health.
Vision: Let’s keep exploring how to push past those barriers that keep us from living our best, healthiest lives.
Report error
Brands of Abbott Healthcare
Medicine
3.9
• 22 reviews
ABECA - AmbitionBox Employee Choice Awards
Best of the best, rated by employees
Abbott won India’s Largest Employee Choice Awards in Large Companies Category.
#3 Top Rated Pharma Company
Share
Abbott Ratings
based on 3.3k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
1.7k
4
827
3
344
2
145
1
199
Category Ratings
4.0
Company culture
4.0
Salary
4.0
Work-life balance
4.0
Skill development
3.8
Job security
3.8
Work satisfaction
3.3
Promotions
Abbott is rated 4.1 out of 5 stars on AmbitionBox, based on 3.3k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Abbott
based on 3.1k reviews
4.0
Rated by 417 Women
Rated 3.9 for Work-life balance and 3.9 for Company culture
4.1
Rated by 2.7k Men
Rated 4.1 for Salary and 4.0 for Work-life balance
Work Policy at Abbott
based on 358 reviews in last 6 months
Work from office
54%
Hybrid
40%
Permanent work from home
6%
Abbott Reviews
Top mentions in Abbott Reviews
+ 5 more
Compare Abbott with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.1/5 based on 3.3k reviews  | 3.8/5 based on 3.7k reviews | 4.3/5 based on 2.1k reviews | 4.2/5 based on 3.4k reviews |
Highly Rated for | Skill development Work-life balance Salary | Job security | Job security Skill development Work-life balance | Salary Job security Work-life balance |
Critically Rated for | Promotions | Promotions |  No critically rated category | No critically rated category |
Primary Work Policy | Work from office 54% employees reported | Work from office 88% employees reported | Work from office 95% employees reported | Work from office 76% employees reported |
Rating by Women Employees | 4.0 Good rated by 417 women | 4.0 Good rated by 385 women | 4.4 Good rated by 341 women | 4.0 Good rated by 342 women |
Rating by Men Employees | 4.1 Good rated by 2.7k men | 3.8 Good rated by 3.1k men | 4.3 Good rated by 1.7k men | 4.2 Good rated by 2.9k men |
Job security | 3.8 Good | 4.0 Good | 4.4 Good | 4.1 Good |
View more
Abbott Salaries
Abbott salaries have received with an average score of 4.0 out of 5 by 3.3k employees.
Territory Business Manager
(901 salaries)
Unlock
₹1.7 L/yr - ₹9.3 L/yr
Therapy Business Manager
(443 salaries)
Unlock
₹3 L/yr - ₹10 L/yr
Area Business Manager
(392 salaries)
Unlock
₹5.4 L/yr - ₹17.3 L/yr
Key Account Manager
(382 salaries)
Unlock
₹4 L/yr - ₹14 L/yr
Territory Sales Manager
(246 salaries)
Unlock
₹3.3 L/yr - ₹12.6 L/yr
Medical Representative
(213 salaries)
Unlock
₹1.5 L/yr - ₹8.5 L/yr
Area Sales Manager
(169 salaries)
Unlock
₹6 L/yr - ₹26.1 L/yr
Sales Development Manager
(100 salaries)
Unlock
₹5.2 L/yr - ₹16.3 L/yr
Territory Manager
(99 salaries)
Unlock
₹3.3 L/yr - ₹10.1 L/yr
Zonal Business Manager
(93 salaries)
Unlock
₹11.5 L/yr - ₹31 L/yr
Abbott Interview Questions
A Senior Executive was asked Q. Describe a time when a breakdown happened and how you resolved it.
An Executive Production was asked Q. What are the principles of induction sealing?
A Process Associate was asked Q. Write a program to generate the Fibonacci sequence.
A HR Recruiter was asked 11mo agoQ. How do you approach candidates to obtain information (role play)?
An Area Business Manager was asked Q. Sell me this bottle of water.
Abbott Jobs
Popular Designations Abbott Hires for
Popular Skills Abbott Hires for
Current Openings
Abbott News
View all
Infringement or Not? DHC Refers Case to Larger Bench to Decide on Actions Against Registered Trademarks
- A Delhi High Court Division Bench referred a case concerning trademark infringement to a larger bench for clarification on actions against registered trademarks.
- The case involved a dispute between Abros Sports International Pvt. Ltd. and Ashish Bansal over the trademarks NEBROS and ABROS related to footwear.
- Key legal questions raised include whether infringement suits can be filed against registered trademark owners and if interim reliefs can be granted in such cases.
- The DB interpreted that the use of a registered trademark by its owner does not constitute infringement, contrasting previous decisions by other benches in the DHC.
- The DB questioned the interplay between Sections 28, 29, 30, and 124 of the Trademarks Act to determine the scope of infringement actions against registered proprietors.
- Rulings in earlier cases like Raj Kumar Prasad v. Abbott Healthcare Pvt. Ltd. conflict with the stance taken by the DB in the current case of Abros Sports International Pvt. Ltd.
- The DB's decision highlights the necessity for a uniform interpretative approach on trademark infringement cases involving registered trademarks.
- The referral to a larger bench aims to resolve the legal divergence and provide clarity on the boundaries of trademark infringement actions in India.
- The significance of distinguishing between passing off and infringement actions in trademark disputes is underlined in the current legal discourse.
- The complexity of the legal landscape surrounding infringement actions against registered trademarks necessitates a comprehensive and consistent framework.
- The comparison with UK trademark laws highlights the need for a nuanced understanding of the implications of registered trademark use and infringement claims.
Spicyip | 26 May, 2025
Stock Market Today: All You Need To Know Going Into Trade On May 16
- Indian benchmark equity indices closed higher on Thursday with NSE Nifty 50 up by 1.6% and BSE Sensex up by 1.48%.
- Foreign portfolio investors were net buyers of Indian equities, while domestic institutional investors turned net sellers.
- Several companies released earnings updates, including LT Foods, Tega Industries, Abbott India, among others.
- Stocks in news included IndusInd Bank, Infosys, Relaxo Footwear, Bharti Airtel, and Larsen & Toubro.
- Insider trades included promotions selling shares in Rajoo Engineers and buying shares in DB Corp.
- Trading tweaks like price band changes, dividends, securities under ASM Framework, and F&O cues were observed.
- The rupee weakened against the US dollar after a three-day winning streak with investors awaiting India's trade data.
- Stock Market updates, major brokerage calls, and trade setup highlighted market activity for the day.
- Companies like Bajaj Auto, Biocon, and Raymond announced strategic decisions, while Alkem Labs faced a cybersecurity incident.
- Key financial highlights and growth roadmap revisions were shared by various companies post-market hours.
Bloomberg Quint | 16 May, 2025
Stock Market Today: All You Need To Know Going Into Trade On May 15
- The NSE Nifty 50 and Sensex closed with gains on Wednesday's trading session, with Nifty ending 0.36% higher at 24,666.90 and Sensex closing 0.22% up at 81,330.56.
- Foreign portfolio investors turned net buyers of Indian equities on Wednesday, purchasing equities worth Rs 931.8 crore, while domestic institutional investors bought equities worth Rs 316.3 crore.
- Key events to watch include the government releasing the trade deficit data for April.
- Earnings in focus include various companies like Abbott India, CESC, Page Industries, Muthoot Finance, and more reporting their financial results.
- Stocks in news involve companies like Wipro, Brigade Enterprises, Kirloskar Brothers, BASF India, Infosys, HUL, Yes Bank, and others announcing significant developments.
- In the currency market, the Indian rupee strengthened against the US dollar on Wednesday, closing at 85.28.
- Trading tweaks include Dynamic Cables shifting its price band, securities being excluded/included in the ASM framework, and companies going ex-record dividend.
- F&O cues reveal Nifty May Futures up by 0.36% to 24,728, with changes in open interest and put-call ratio.
- Bulk deals and block deals include transactions in shares of companies like Max Healthcare, Info Edge, Navin Fluorine International, and more.
- The article provides a comprehensive overview of the stock market activities, corporate earnings, trading updates, and currency movements for investors to stay informed.
Bloomberg Quint | 15 May, 2025
Pediatric Academic Societies Awards 33 Trainee Travel Grants for PAS 2025 Meeting
- The Pediatric Academic Societies (PAS) awarded 33 Trainee Travel Grants for their PAS 2025 Meeting, recognizing exceptional emerging scholars in pediatric research.
- The grants include complimentary registration and a $500 travel stipend, encouraging innovative contributions and nurturing future leaders in pediatric medicine.
- Awardees span diverse backgrounds like medical students, resident physicians, and fellows, emphasizing PAS's commitment to supporting pediatricians at all career stages.
- The grants focus on supporting early-career investigators and fostering translational research, bridging basic science to patient-centered outcomes in pediatric health.
- PAS Meeting serves as a global platform for researchers and clinicians to share advancements in various pediatric subspecialties, promoting collaboration and growth.
- Industry sponsorship from Abbott and Mead Johnson Nutrition supports the grants, facilitating networking, mentorship, and professional development for trainees.
- Participants from institutions like Boston Children’s Hospital and Johns Hopkins contribute to pediatric research in areas such as hospital medicine, nephrology, and emergency care.
- The grants highlight the importance of mentorship within pediatrics, fostering investigative skills and advancing evidence-based interventions for child health challenges.
- PAS's mission to advance child health aligns with the grants' goal of empowering young investigators to disseminate findings and integrate into the pediatric research community.
- Trainees focus on urgent public health priorities in pediatric research, including neonatal outcomes, nutritional strategies, and addressing disparities in access to care.
Bioengineer | 22 Apr, 2025
Kotak Alternate invests in nutraceuticals CDMO Tirupati Medicare
- Kotak Alternate has invested in nutraceuticals contract development and manufacturing organization (CDMO) Tirupati Medicare.
- The investment supports Tirupati's expansion plans and facilitates a complete exit of the existing investor Affirma Capital.
- Tirupati is the largest player in the Indian nutraceutical CDMO space, catering to companies such as Herbalife, Abbott, and Glanbia.
- The investment will assist Tirupati in preparing for an IPO and exploring growth opportunities, including inorganic growth.
HinduBusinessLine | 26 Mar, 2025
Six Stocks That Made Significant MovesV
- Ulta Beauty (ULTA) rose by 13.68% on strong stock buyback program despite weak earnings.
- Microstrategy (MSTR) gained 13% as it continues to trade in a downtrend amidst rising bitcoin (BTC-USD) price.
- Crown Castle (CCI) surged 10.4% on better-than-expected fund flows and revenue.
- Abbott (ABT) slumped after a judge ordered a new trial in a baby formula-related case, closing below $140.
Baystreet | 17 Mar, 2025
Stocks To Buy: Abbott India, Bajaj Finance, Bharat Forge, Chambal Fertilizers
- Analysts have buy calls on Abbott India, Bajaj Finance, Bharat Forge, and Chambal Fertilizers.
- Aditya Agarwal suggests a 'buy' for Abbott India with a target price of Rs 31,700 apiece.
- Aditya Agarwala has a buy call on Bajaj Finance with a target price of Rs 9,000.
- Reliance Securities' Vikas Jain recommends a 'buy' for Bharat Forge with a target price of Rs 1,170 apiece.
Bloomberg Quint | 27 Feb, 2025
Optimus’ Linezolid Patent Revoked After Post-Grant Opposition
- The Indian Patent Office has revoked Patent No. 281489 held by Optimus after a post-grant opposition by Symed Labs.
- The patent was revoked due to lacking obviousness/inventive step and not being a patentable invention under section 3(d) and section 8 of the Patents Act.
- Linezolid, the subject of the patent, is an antibiotic used against pneumonia, skin infections, and drug-resistant tuberculosis.
- The drug is part of the National Pharmaceutical Pricing Authority's list with a fixed price, followed by a challenge by Abbott Healthcare, rejected in October 2024.
- The post-grant opposition process had several rounds of back and forth before a hearing took place in June 2024.
- Grounds for opposition included anticipation by prior publication, anticipation by prior claiming, obviousness, lack of inventive step, and not being a new invention.
- The patent office found that the claims were not anticipated by prior publication or claiming, but lacked inventive step and did not represent a new invention.
- The decision questioned the level of scrutiny by the patent office on procedural requirements like disclosure under section 8.
- The analysis focused on grounds like obviousness and non-patentability under section 3(d), highlighting the need for stringent examination in pharmaceutical patents.
- The opponent in the case, Symed Labs, had a history of litigating against patents related to Linezolid and specific infringement claims in the past.
Spicyip | 24 Feb, 2025
RP Sanjiv Goenka Group elevates Janesh K to VP-group corporate HR
- RP Sanjiv Goenka Group has elevated Janesh K to the role of VP-group corporate HR.
- Janesh K moves from RP-SG FMCG (Guiltfree Industries) where he was CHRO since 2020.
- In his new role, Janesh will spearhead HR excellence initiatives and contribute to strategic HR programs.
- He will be based out of Kolkata.
HRKatha | 28 Jan, 2025
Powered by
Abbott Subsidiaries
Abbott Diabetes Care
3.7
• 39 reviews
Abbott Vascular
4.5
• 15 reviews
St. Jude Medical
3.1
• 12 reviews
Abbott Point of Care
4.2
• 4 reviews
Inverness Medical Innovations
1.0
• 1 review
Report error
Compare Abbott with
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
3.9
DIVI'S Laboratories
3.7
Teva Pharmaceuticals
4.0
Sanofi
4.2
Piramal Pharma
4.0
Fresenius Kabi
4.1
Novo Nordisk
4.0
AstraZeneca
4.0
Eli Lilly and Company
3.7
Sandoz
3.9
Par Pharmaceutical Companies
4.3
Novartis Healthcare
4.1
Apex Laboratories
3.9
Agilent Technologies
4.1
Merck
4.2
Pfizer Products India
4.0
Universal Corporation
3.6
Boehringer-Ingelheim
4.0
Global Calcium
3.4
Contribute & help others!
You can choose to be anonymous
Companies Similar to Abbott
4.3
• 2.1k reviews
GlaxoSmithKline Pharmaceuticals
Biotech & Life sciences, Healthcare / Pharma, Manufacturing, Pharma
4.1
• 2k reviews
Pfizer
Healthcare / Pharma, Manufacturing, Pharma
3.9
• 1.9k reviews
DIVI'S Laboratories
Pharma
3.7
• 1.5k reviews
Teva Pharmaceuticals
Healthcare / Pharma, Clinical Research, Pharma
4.0
• 1.3k reviews
Sanofi
Biotech & Life sciences, Manufacturing, Analytics & KPO, Pharma
4.2
• 1.3k reviews
Piramal Pharma
Biotech & Life sciences, Pharma
4.0
• 1.2k reviews
Fresenius Kabi
Manufacturing, Analytics & KPO, Pharma
4.1
• 1.1k reviews
Novo Nordisk
Internet, Pharma
4.0
• 1k reviews
AstraZeneca
Biotechnology, Pharma
4.0
• 886 reviews
Abbott FAQs
When was Abbott founded?
Abbott was founded in 1888. The company has been operating for 137 years primarily in the Pharma sector.
Where is the Abbott headquarters located?
Abbott is headquartered in Illinois City, Illinois. It operates in 5 cities such as Mumbai, New Delhi, Patna, Jaipur, Panchkula. To explore all the office locations, visit Abbott locations.
How many employees does Abbott have in India?
Abbott currently has more than 3,800+ employees in India. Marketing & Communication department appears to have the highest employee count in Abbott based on the number of reviews submitted on AmbitionBox.
Does Abbott have good work-life balance?
Abbott has a work-life balance rating of 4.0 out of 5 based on 3,200+ employee reviews on AmbitionBox. 79% employees rated Abbott 4 or above on work-life balance. This rating reflects the company's efforts to help employees maintain a healthy balance between their personal and professional lives. We encourage you to read Abbott work-life balance reviews for more details.
Is Abbott good for career growth?
Career growth at Abbott is rated as moderate, with a promotions and appraisal rating of 3.3. 21% employees rated Abbott 3 or below, while 79% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Abbott promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in Abbott?
Working at Abbott comes with several advantages and disadvantages. It is highly rated for company culture, salary & benefits and skill development. However, it is poorly rated for promotions / appraisal, based on 3,200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
